Enzalutamide-induced and PTH1R-mediated TGFBR2 degradation in osteoblasts confers resistance in prostate cancer bone metastases
Shang Su, Jingchen Cao, Xiangqi Meng, Ruihua Liu, Alexandra Vander Ark, Erica Woodford, Reian Zhang, Isabelle Stiver, Xiaotun Zhang, Zachary Madaj, Megan J. Bowman, Yingying Wu, H. Eric Xu, Bin Chen, Haiquan Yu, Xiaohong Li
Topics & Concepts
EnzalutamideProstate cancerOsteoblastCancer researchTumor microenvironmentMedicineCancerChemistryInternal medicineIn vitroTumor cellsAndrogen receptorBiochemistryProstate Cancer Treatment and ResearchBone health and treatmentsCancer-related Molecular Pathways